We develop, partner or procure synergistic immuno-assay platforms, technology solutions and model systems. Our areas of interest and expertise are in primary tissues, human cell lines, 3D platforms, micro-fluidics, animal model systems, data analytics platforms and imaging solutions.
The immune system is made up of a network of cells, tissues, and organs that work together to protect the body against infectious organisms and other invaders. The immune system has an essential role in various diseases. New techniques and technologies have led to an in-depth understanding of the various immune cells in the context of disease biology.
This understanding has paved the way for the development of novel drugs and diagnostics and an increased investment by pharmaceutical and biotechnology companies in immune-mediated disease research.
We aim to bring efficiency and expediency to the drug development process by incorporating research data, real-world patient data and clinical evidence into the selection of cells, assays and platforms. We believe this systematic approach coupled with technology solutions, -omics and instrumentation should lead to meaningful drug development solutions and in turn accelerate drug development
Rising research and development costs and timelines are key contributors to drug pricing. Our mission is to study the preclinical or early stages of R&D and identify (or develop) innovative approaches that can aide bio-pharmaceutical companies in obtaining cost-effective proof-of-concept data.